Precigen's therapy was approved by the FDA and listed on Nasdaq, while Trump-era tariffs are reported to benefit certain AI stocks.
3 reports, 3 independent
Updated Wed 00:00
No new developments lately
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Precigen's therapy was approved by the FDA and listed on Nasdaq, while Trump-era tariffs are reported to benefit certain AI stocks.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.FDA granted Platform Technology Designation to Precigen.1 source
Precigen drug approved by FDA and listed on Nasdaq; Trump tariffs benefit AI stocks.1 source